Asymptomatic pulmonary embolism following pacemaker implantation

Area of Science:

• Cardiology
• Vascular Surgery

Background:

• Pulmonary embolism (PE) is a potential complication following pacemaker implantation.
• Prophylactic anticoagulation strategies are often considered to mitigate this risk.

Purpose of the Study:

• To determine the incidence of pulmonary embolism (PE) after pacemaker implantation.
• To evaluate the efficacy of postoperative prophylactic low-dose heparin therapy in preventing PE.

Main Methods:

• A prospective, randomized controlled trial involving 40 patients undergoing pacemaker implantation.
• Patients were assigned to receive either low-dose heparin or no treatment (control group).
• Pulmonary scintigraphy was used to detect perfusion defects before implantation, at two weeks, and 12 months post-implantation.

Main Results:

• Three cases of pulmonary embolism (perfusion defects) were observed in the control group within 14 days post-implantation.
• No pulmonary embolism events occurred in the group receiving prophylactic heparin therapy.
• The overall incidence of asymptomatic pulmonary embolism in the untreated group was 15%.

Conclusions:

• Postoperative prophylactic low-dose heparin therapy appears effective in preventing pulmonary embolism after pacemaker implantation.
• A 15% incidence of asymptomatic pulmonary embolism occurs in patients not receiving prophylactic heparin.
• Further research may confirm heparin's role in reducing PE risk in this patient population.